Search

Ali Neyzari

Examiner (ID: 5298, Phone: (571)272-7622 , Office: P/2687 )

Most Active Art Unit
2627
Art Unit(s)
2502, 2655, 2627, 2687, 2656, 2651, 2686, 2653, 2516, 2752
Total Applications
2463
Issued Applications
2234
Pending Applications
33
Abandoned Applications
204

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6178702 [patent_doc_number] => 20020156264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => '22012, a novel human carboxypeptidase' [patent_app_type] => new [patent_app_number] => 10/068134 [patent_app_country] => US [patent_app_date] => 2002-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27744 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156264.pdf [firstpage_image] =>[orig_patent_app_number] => 10068134 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/068134
22012, a novel human carboxypeptidase Feb 5, 2002 Abandoned
Array ( [id] => 6779361 [patent_doc_number] => 20030050443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Prostate specific secreted protein' [patent_app_type] => new [patent_app_number] => 10/054976 [patent_app_country] => US [patent_app_date] => 2002-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 49323 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050443.pdf [firstpage_image] =>[orig_patent_app_number] => 10054976 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/054976
Prostate specific secreted protein Jan 24, 2002 Abandoned
Array ( [id] => 6442093 [patent_doc_number] => 20020128463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Novel human mitochondrial membrane protein' [patent_app_type] => new [patent_app_number] => 10/038302 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17655 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128463.pdf [firstpage_image] =>[orig_patent_app_number] => 10038302 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/038302
Novel human mitochondrial membrane protein Jan 3, 2002 Abandoned
Array ( [id] => 7034520 [patent_doc_number] => 20050033030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Humanised antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/433349 [patent_app_country] => US [patent_app_date] => 2001-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3717 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20050033030.pdf [firstpage_image] =>[orig_patent_app_number] => 10433349 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/433349
Humanised antibodies and uses thereof Nov 28, 2001 Abandoned
Array ( [id] => 5969340 [patent_doc_number] => 20020091249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Human tumor suppressor polypeptides' [patent_app_type] => new [patent_app_number] => 09/970518 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17160 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091249.pdf [firstpage_image] =>[orig_patent_app_number] => 09970518 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/970518
Human tumor suppressor polypeptides Oct 2, 2001 Abandoned
09/831794 Influencing angiogenesis using CD66a Aug 2, 2001 Abandoned
09/806301 Novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers Jul 26, 2001 Abandoned
Array ( [id] => 5999782 [patent_doc_number] => 20020028472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Methods for identifying inhibitors of the anaphase promoting complex' [patent_app_type] => new [patent_app_number] => 09/893443 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8684 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028472.pdf [firstpage_image] =>[orig_patent_app_number] => 09893443 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/893443
Methods for identifying inhibitors of the anaphase promoting complex Jun 28, 2001 Abandoned
09/744406 Allogeneic cellular immunogens useful as cancer vaccines Jan 21, 2001 Abandoned
Array ( [id] => 520054 [patent_doc_number] => 07189816 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-13 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 10/088639 [patent_app_country] => US [patent_app_date] => 2000-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 9751 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189816.pdf [firstpage_image] =>[orig_patent_app_number] => 10088639 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/088639
Compounds Oct 25, 2000 Issued
09/635974 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists Aug 8, 2000 Abandoned
Array ( [id] => 634273 [patent_doc_number] => 07129330 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-31 [patent_title] => 'Multivalent antibody constructs' [patent_app_type] => utility [patent_app_number] => 09/674794 [patent_app_country] => US [patent_app_date] => 1999-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4830 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129330.pdf [firstpage_image] =>[orig_patent_app_number] => 09674794 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/674794
Multivalent antibody constructs May 4, 1999 Issued
Array ( [id] => 650747 [patent_doc_number] => 07112324 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-26 [patent_title] => 'CD 19×CD3 specific polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/673735 [patent_app_country] => US [patent_app_date] => 1999-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 22 [patent_no_of_words] => 16744 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112324.pdf [firstpage_image] =>[orig_patent_app_number] => 09673735 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/673735
CD 19×CD3 specific polypeptides and uses thereof Apr 20, 1999 Issued
Array ( [id] => 5873457 [patent_doc_number] => 20020048578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'ANTIBODY VARIANTS' [patent_app_type] => new [patent_app_number] => 09/125460 [patent_app_country] => US [patent_app_date] => 1998-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9283 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048578.pdf [firstpage_image] =>[orig_patent_app_number] => 09125460 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/125460
ANTIBODY VARIANTS Aug 18, 1998 Abandoned
Array ( [id] => 708149 [patent_doc_number] => 07060808 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-13 [patent_title] => 'Humanized anti-EGF receptor monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 08/973065 [patent_app_country] => US [patent_app_date] => 1996-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 22 [patent_no_of_words] => 23870 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060808.pdf [firstpage_image] =>[orig_patent_app_number] => 08973065 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/973065
Humanized anti-EGF receptor monoclonal antibody Jun 6, 1996 Issued
Array ( [id] => 6791578 [patent_doc_number] => 20030086922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'METHOD OF PROMOTING AN IMMUNE RESPONSE WITH A BISPECIFIC ANTIBODY' [patent_app_type] => new [patent_app_number] => 08/349489 [patent_app_country] => US [patent_app_date] => 1994-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10263 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086922.pdf [firstpage_image] =>[orig_patent_app_number] => 08349489 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/349489
METHOD OF PROMOTING AN IMMUNE RESPONSE WITH A BISPECIFIC ANTIBODY Dec 1, 1994 Abandoned
Menu